872-06-0

Basic information

• Product Name: 9-chloronon-1-ene
• Synonyms: 1-nonene, 9-chloro-; 9-chloro-1-nonene
• CAS NO: 872-06-0
• Molecular Formula: C9H17Cl
• Molecular Weight: 160.69
• Mol File: 872-06-0.mol

Chemical Properties

• Boiling Point: 202.5°Cat760mmHg
• Flash Point: 73.2°C
• Appearance: /
• Density: 0.875g/cm³
• Vapor Pressure: 0.414mmHg at 25°C
• Refractive Index: 1.439
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 9-chloronon-1-ene(CAS DataBase Reference)
• NIST Chemistry Reference: 9-chloronon-1-ene(872-06-0)
• EPA Substance Registry System: 9-chloronon-1-ene(872-06-0)

Safety Data

• Hazardous Substances Data: 872-06-0(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
9-chloronon-1-ene is used as a key intermediate in the synthesis of various organic compounds due to its reactivity and ability to undergo further chemical reactions.
Used in Detergent Production:
In the detergent industry, 9-chloronon-1-ene is used as a precursor to produce surfactants, which are essential for the cleaning properties of detergents.
Used in Lubricant Formulation:
9-chloronon-1-ene is also utilized in the formulation of lubricants, where it contributes to the viscosity and performance characteristics of the final product.
Used in Plasticizer Manufacturing:
9-chloronon-1-ene is used as a starting material in the production of plasticizers, which are additives that increase the flexibility and workability of plastics.
Safety Considerations:
It is crucial to handle and store 9-chloronon-1-ene with care due to its flammability and potential for causing harm if it comes into contact with the skin or eyes. Proper safety measures should be implemented during its use in industrial processes.

InChI:InChI=1/C9H17Cl/c1-2-3-4-5-6-7-8-9-10/h2H,1,3-9H2

Upstream product

• 361541-51-7 (6-chlorohexyl)magnesium bromide 
• 106-95-6 allyl bromide 
• 6294-17-3 1-bromo-6-chlorohexane 
• 54512-75-3 1-bromo-5-chloropentane 
• 7103-09-5 4-but-1-enylmagnesium bromide 

Downstream Products

• 1307310-19-5 C₂₂H₃₄O₂ 
• 183598-36-9 non-8-en-1-ylcyclohexane 
• 1307310-17-3 4-(9-cyclohexylnonyl)benzaldehyde 

Relevant articles and documents

Method of manufacturing sulfonylhalides unsatd. alkyl

PROBLEM TO BE SOLVED: To provide a production method capable of industrially simply and efficiently providing unsaturated alkyl halides useful as functional compounds, pharmaceuticals, agrochemicals or intermediates thereof.SOLUTION: Vinyl chloride and a Grignard reagent derived from a dihaloalkane represented by the specified general formula (1), where Xand Xeach independently represent Cl, Br or I and n represents an integer from 4 to 12, are reacted in the presence of an iron compound to produce unsaturated alkyl halides represented by the specified general formula (2), where Xrepresents Cl, Br or I and n represents an integer from 4 to 12.

Copper-Catalyzed Cross-Coupling Reaction of Allyl Boron Ester with 1°/2°/3°-Halogenated Alkanes

The cross-coupling reaction of allyl boron ester with 1°/2°/3°-halogenated alkanes in the presence of copper has been developed for the first time, which provides a mild and efficient method for the construction of saturated C(sp3)-C(sp3) bonds. This protocol shows excellent compatibility with the nonactivated primary, secondary, and even tertiary halogenated alkanes under mild conditions.

Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells

Sphingosine 1-phosphate (S1P) is a bioactive lipid that has been identified as an accelerant of cancer progression. The sphingosine kinases (SphKs) are the sole producers of S1P, and thus, SphK inhibitors may prove effective in cancer mitigation and chemosensitization. Of the two SphKs, SphK1 overexpression has been observed in a myriad of cancer cell lines and tissues and has been recognized as the presumptive target over that of the poorly characterized SphK2. Herein, we present the design and synthesis of amidine-based nanomolar SphK1 subtype-selective inhibitors. A homology model of SphK1, trained with this library of amidine inhibitors, was then used to predict the activity of additional, more potent, inhibitors. Lastly, select amidine inhibitors were validated in human leukemia U937 cells, where they significantly reduced endogenous S1P levels at nanomolar concentrations.

Biologically active compounds by catalytic olefin metathesis

Biologically active compounds such as pheromones and precursors thereof are produced by catalyzed cross metathesis of dissimilar terminal olefins or of a cyclodiene and a terminal olefin.